FDA's national active surveillance network coming soon

04/2/2008 | RPM Report (free registration), The

FDA Commissioner Andrew von Eschenbach recently said the agency plans soon to unveil Sentinel, a national active surveillance network. The potential implications could be "truly revolutionary" for drug companies and will depend on who implements the program, and how, this RPM Report analysis says.

View Full Article in:

RPM Report (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC